NCT00327626View on ClinicalTrials.gov

Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 1, 2006

Primary Completion Date

February 1, 2007

Study Completion Date

March 1, 2007

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

ISIS 113715

Trial Locations (5)

13100

ZIV Hospital, Safed

22100

Western Galilee Medical Center - Nahariya, Nahariya

31096

Rambam Medical Center, Haifa

76100

Kaplan Medical Center, Rehovot

84101

Soroka Medical Center, Beersheba

Sponsors
All Listed Sponsors
lead

Ionis Pharmaceuticals, Inc.

INDUSTRY